GrayMatters Health Ltd.
Personalizing Self Neuro-Modulation Therapy for Major Depressive Disorder (MDD) using Clinical Biomarkers for MDD Subtypes — Israeli partner. US partner: The McLean Hospital Corporation (Belmont (Massachusetts)). Sector: Life Sciences, Medical Devices.